Division of Molecular Medicine
The Division of Molecular Medicine examines the cells and biomolecular complexes ("molecular machines") responsible for fundamental processes, including immune responses, cell division, and protein synthesis, which, when defective, cause diseases such as cancers, infections, and autoimmunity. Investigations are aimed at devising new diagnostic tools and therapies, such as changes at the molecular or cellular level that may have prognostic value.
The Division houses a national biotechnology resource in microscopy and core facilities in protein production and macromolecular analyses. Proficiency testing in cytology screening, immunology, hematology, tumor markers, and clinical chemistry is conducted, and the quality of products and services provided by blood and tissue banks is assured through the Blood and Tissue Resources Program.
Division Laboratories:
- Blood and Tissue Resource Program
- Cellular Regulation
- Clinical and Experimental Endocrinology and Immunology
- Computational Biology and Molecular Imaging
- Diagnostic Oncology
- Molecular Diagnostics
- Molecular Screening Technologies
- Structural Pathology